SDS Optic SA Sustainability Reports
SDS Optic S.A. develops innovative medical DeepTech diagnostic technologies, connecting molecular biology with novel photonics. Its primary platform, inPROBE, functions as a real-time fiber-optic micro-biosensor for early-stage cancer diagnosis and targeted treatment monitoring.
Sector: Manufacturing
Country: Poland
Exchange: Warsaw Stock Exchange
LEI: 259400G9MUCF7RQLHQ45
FIGI: BBG0161GRH65
2 reports from 2022 to 2025